FIELD: medicine, mammology.
SUBSTANCE: additionally to cytological research one should study the content of mammary gland due to a solid-phase immunoenzymatic assay for the presence of endometrial protein alpha-2-microglobulin of fertility (AMGF). Detection of AMGF in cystic content enables to prove cytological diagnosis (at 80% potential) of intracystic mammary cancer. Absence of AMFF in the content of mammary cysts enables to prove cytological diagnosis of fibrous-cystic disease at 99% potential.
EFFECT: higher efficiency verification.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EARLY DIAGNOSTICS OF OVARY TUMOURS | 2007 |
|
RU2334986C1 |
| METHOD FOR SCREENING DIAGNOSTICS OF MAMMARY DISEASES ACCOMPANIED WITH GALACTORRHEA SYNDROME | 2003 |
|
RU2240562C2 |
| METHOD FOR ESTIMATING ENDOMETRIUM CONDITION IN FEMALE GENITALIA NEOPLASM CASES | 2005 |
|
RU2290639C1 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING TUMOR PROCESSES IN OVARIES | 2006 |
|
RU2313794C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR MALIGNANT AND BENIGN BREAST PATHOLOGY | 2013 |
|
RU2530557C1 |
| METHOD FOR PREDICTION OF RISK OF DETECTION OF MINOR BREAST CANCER ACCOMPANYING FIBROCYSTIC BREAST DISEASE | 2013 |
|
RU2547802C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF MAMMARY GLAND DISEASES | 2005 |
|
RU2296511C1 |
| METHOD FOR MATCHING THE ACCESS OF OPERATIVE INTERFERENCE AT OVARIAN TUMORS | 2005 |
|
RU2283499C1 |
| EARLY BREAST CANCER SCREENING METHOD | 2023 |
|
RU2823464C1 |
| METHOD FOR DIAGNOSTICS OF ENDOMETRIUM PATHOLOGY IN PATIENTS WITH HYSTEROMYOMA | 2007 |
|
RU2334987C1 |
